Jubilee fever (Q fever) - Symptoms, Causes, Treatment & Prevention

📅 Updated: July 2026 ⏱️ 7 min read ✅ Medically reviewed
```html Jubilee Fever (Q Fever) – Complete Medical Guide

Jubilee Fever (Q Fever) – Comprehensive Medical Guide

Overview

Jubilee fever, more commonly known as Q fever, is a zoonotic infection caused by the bacterium Coxiella burnetii. The term “Q” stands for “query” because the disease’s cause was unknown when it was first described in the 1930s in Queensland, Australia.

  • Who it affects: Anyone can become infected, but people who work with livestock (sheep, goats, cattle), veterinarians, abattoir workers, and farmers are at the highest risk.
  • Geographic prevalence: Q fever is reported worldwide, with the highest incidence in Australia, the Netherlands, Spain, and parts of the United States. In Australia, >5,000 cases have been reported since the 1990s, with a median of ~300 cases per year (Mayo Clinic, 2023). In the United States, the CDC estimates 1–3 cases per million people annually.
  • Seasonality: Outbreaks often occur in the spring and early summer when birthing seasons increase aerosolised bacterial load.

The infection can be acute (flu‑like illness) or progress to a chronic form that may involve the heart, liver, or blood vessels. Early recognition is essential because chronic Q fever carries a mortality rate of up to 25 % if untreated (WHO, 2022).

Symptoms

Symptoms vary based on whether the infection is acute or chronic. Many people are asymptomatic, especially after low‑dose exposure.

Acute Q Fever (usually 2‑4 weeks after exposure)

  • Fever: Sudden high temperature (often 38.5–40 °C) that may be intermittent.
  • Headache: Often severe and throbbing.
  • Myalgia & arthralgia: Muscle and joint pains, especially in the lower back and knees.
  • Fatigue: Persistent tiredness that can last weeks to months.
  • Respiratory: Dry cough or shortness of breath; rarely, pneumonia.
  • Gastro‑intestinal: Nausea, vomiting, abdominal pain, or diarrhea.
  • Hepatitis: Mild elevation of liver enzymes; patients may feel right‑upper‑quadrant discomfort.
  • Rash: A maculopapular or petechial rash in <5 % of cases.

Chronic Q Fever (weeks to years after initial infection)

  • Endocarditis: Fever, night sweats, weight loss, new or worsening heart murmur, and embolic phenomena.
  • Vascular infection: Aneurysm formation or infection of existing prosthetic vessels.
  • Chronic hepatitis: Persistent fatigue, jaundice, and markedly elevated liver enzymes.
  • Fatigue & malaise: Often profound and debilitating.
  • Weight loss & night sweats: Common in systemic involvement.

Causes and Risk Factors

What causes Q fever?

The bacterium Coxiella burnetii is highly resilient and can survive in the environment for months. Transmission occurs primarily through inhalation of contaminated aerosols from the birth products (placenta, amniotic fluid), urine, feces, or milk of infected animals. Less common routes include:

  • Direct skin contact with infected animal fluids (especially if there are cuts).
  • Ingestion of unpasteurised dairy products.
  • Ticks – they can harbour the organism, though human transmission via tick bite is rare.

Who is at higher risk?

  • Livestock workers (sheep, goats, cattle) – especially during birthing season.
  • Veterinarians, animal breeders, abattoir personnel.
  • People living near farms or large animal breeding facilities.
  • Laboratory workers handling Coxiella cultures.
  • Individuals with pre‑existing heart valve disease, prosthetic heart valves, or vascular grafts – they are more likely to develop chronic Q fever.
  • Immunocompromised patients (e.g., HIV, organ transplant recipients).

Diagnosis

Diagnosing Q fever can be challenging because its symptoms mimic many other infections. A combination of clinical suspicion, exposure history, and laboratory testing is required.

Laboratory Tests

  • Serology (IgG & IgM) – The most widely used test. A four‑fold rise in IgG titres between acute and convalescent samples confirms infection. Coxiella Phase I and Phase II antibodies differentiate acute (high Phase II) from chronic disease (high Phase I).
  • Polymerase Chain Reaction (PCR) – Detects bacterial DNA in blood, tissue, or respiratory specimens. PCR is especially useful early in the illness before antibodies develop.
  • Complete blood count (CBC) – May show mild leucocytosis or, less commonly, leukopenia.
  • Liver function tests – Often mildly elevated transaminases.
  • Echocardiography – Indicated when chronic Q fever endocarditis is suspected.

Diagnostic Criteria (CDC/WHO)

  1. Compatible clinical syndrome (fever ≥38 °C, headache, myalgia, etc.).
  2. Epidemiologic link to a known source (farm work, recent birthing season, etc.).
  3. Laboratory confirmation (serology or PCR).

Treatment Options

Antibiotic therapy is the cornerstone for both acute and chronic Q fever. Early treatment reduces the risk of chronic complications.

Acute Q Fever

  • Doxycycline 100 mg orally twice daily for 14 days – First‑line therapy (recommended by CDC and WHO).
  • If doxycycline cannot be used (e.g., pregnancy, allergy):
    – Trimethoprim‑sulfamethoxazole (TMP‑SMX) 800/160 mg PO twice daily for 14 days (alternative, less effective).

Chronic Q Fever

  • Doxycycline 100 mg PO twice daily **plus** Hydroxychloroquine 200 mg PO three times daily for ≥18 months (often 24–36 months).
  • Therapeutic drug monitoring is required because hydroxychloroquine raises intracellular pH, enhancing doxycycline activity.
  • For patients with prosthetic valve endocarditis or vascular infection, longer courses (up to 36 months) and possible surgical intervention are recommended.

Supportive Care

  • Fever control with acetaminophen (avoid NSAIDs if hepatic involvement is severe).
  • Hydration and rest.
  • Monitoring liver enzymes and renal function during prolonged therapy.

Living with Jubilee Fever (Q Fever)

Even after successful treatment, many patients report lingering fatigue and occasional relapses. Below are practical strategies for long‑term well‑being.

  • Schedule regular follow‑up: Serology every 3–6 months for the first two years to ensure titres are falling.
  • Maintain a symptom diary: Note fever spikes, fatigue levels, and new joint pain – this helps clinicians detect chronic disease early.
  • Heart health monitoring: Annual echocardiograms for those with prior valve disease or prosthetic material.
  • Vaccination: In Australia, the Q‑Vax™ vaccine is available for high‑risk workers; discuss eligibility with your doctor.
  • Balanced nutrition: Emphasise protein, iron, and B‑vitamins to combat fatigue.
  • Gradual return to activity: Begin with low‑impact exercise (walking, swimming) and increase intensity as tolerated.
  • Psychological support: Chronic fatigue can affect mental health; consider counseling or support groups.

Prevention

Because Q fever is transmitted from animals to humans, control measures focus on reducing exposure to infected aerosols.

  • Personal protective equipment (PPE): Wear N95 or higher‑efficiency respirators, gloves, and eye protection when handling birthing products or cleaning animal areas.
  • Environmental controls: Keep animal birthing areas well‑ventilated; use high‑efficiency particulate air (HEPA) filtration where possible.
  • Hygiene practices: Wash hands thoroughly after animal contact; avoid touching the face.
  • Food safety: Consume only pasteurised milk and dairy products.
  • Animal health monitoring: Test herds for Coxiella and cull or treat infected animals as advised by veterinary authorities.
  • Vaccination: In countries where the Q‑Vax™ vaccine is licensed (Australia, some European trials), vaccinate high‑risk workers after proper skin testing.
  • Public health reporting: Promptly report suspected outbreaks to local health departments to initiate control measures.

Complications

If untreated or inadequately treated, Q fever can lead to serious, sometimes life‑threatening complications.

  • Chronic Q fever endocarditis: The most common severe manifestation; mortality up to 25 % without long‑term antibiotics.
  • Vascular infection: Infected aneurysms or prosthetic graft infections that may rupture.
  • Granulomatous hepatitis: Persistent liver inflammation, fibrosis, or cirrhosis.
  • Pregnancy complications: Miscarriage, stillbirth, or pre‑term delivery in infected mothers.
  • Chronic fatigue syndrome‑like illness: Prolonged disabling fatigue lasting >6 months.
  • Neurological involvement: Rare meningitis, encephalitis, or peripheral neuropathy.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, high‑grade fever (>39.5 °C) that does not improve with antipyretics.
  • Severe chest pain or shortness of breath suggesting possible endocarditis or pulmonary involvement.
  • Rapidly worsening abdominal pain, especially in the right upper quadrant, indicating possible severe hepatitis.
  • Unexplained confusion, seizures, or neurological deficits.
  • Persistent vomiting or diarrhoea leading to dehydration (dry mouth, dizziness, low urine output).
  • Signs of an aneurysm rupture – sudden severe back or abdominal pain, a pulsatile abdominal mass, or loss of consciousness.

Prompt medical attention can be lifesaving, especially in cases of chronic Q fever endocarditis or vascular infection.

References

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References